Literature DB >> 3900800

Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.

B Hammer, E Deisenhammer.   

Abstract

The side effects associated with the use of Iotrol were determined in 100 patients and compared with metrizamide and iopamidol in two double-blind studies. The relevance of the distribution of the contrast medium in the CSF space to the occurrence of headache is discussed. The low persistence of iotrol in the brain parenchyma is demonstrated on CT density profiles, compared with metrizamide and iopamidol. Iotrol seems to be the safest contrast substance for intrathecal use.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3900800     DOI： 10.1007/bf00339568

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  16 in total

1.  Kinetics of horseradish peroxidase migration through cerebral cortex.

Authors:  R O Dunker; A B Harris; D P Jenkins
Journal:  Brain Res       Date:  1976-12-17       Impact factor: 3.252

Review 2.  Kinetics of water-soluble contrast media in the central nervous system.

Authors:  M R Sage
Journal:  AJR Am J Roentgenol       Date:  1983-10       Impact factor: 3.959

3.  Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.

Authors:  B Hammer; W Lackner
Journal:  Neuroradiology       Date:  1980-04       Impact factor: 2.804

4.  Absorption of metrizamide from cereb rospinal fluid to blood: pharmacokinetics in humans.

Authors:  K Golman
Journal:  J Pharm Sci       Date:  1975-03       Impact factor: 3.534

5.  Clinical trial of iotrol for lumbar myelography.

Authors:  T Skutta; H Vogelsang; M Galanski; B Hammer; H J Weinmann
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

6.  Brain parenchyma penetration by intrathecal nonionic iopamidol.

Authors:  M R Sage; J Wilcox
Journal:  AJNR Am J Neuroradiol       Date:  1983 Nov-Dec       Impact factor: 3.825

7.  Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis.

Authors:  M Sovak; R Ranganathan; C W Kerber; R Bickford; J F Alksne
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

8.  The effect of position of patient on the passage of metrizamide (Amipaque), meglumine locarmate (Dimer X) and ioserinate (Myelografin) into the blood after lumbar myelography.

Authors:  U Speck; R Schmidt; V Volkhardt; H Vogelsang
Journal:  Neuroradiology       Date:  1978-02-17       Impact factor: 2.804

9.  The distribution of 125I-metrizamide and 125I-diatrizoate between blood, brain and cerebrospinal fluid in the rabbit.

Authors:  J D Fenstermacher; M W Bradbury; G du Boulay; B E Kendall; E W Radu
Journal:  Neuroradiology       Date:  1980       Impact factor: 2.804

10.  Nonionic dimer: development and initial testing of an intrathecal contrast agent.

Authors:  M Sovak; R Ranganathan; U Speck
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105
View more
  1 in total

1.  Rate of clearance of intrathecal iopamidol in the dog.

Authors:  J Wilcox; C A Evill; M R Sage
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.